Concentrated 7-OH — press packet
Media contact
- Brian Harris, MD — Addiction Medicine · Anesthesiology · Sleep Medicine
- Email: info@7-oh.help · Phone: (650) 308-4845
- Press page: https://7-oh.help/press/
- Headshot: high-resolution JPG
Status at a glance
- No temporary scheduling order placing concentrated 7-hydroxymitragynine (7-OH) in Schedule I has been published as of this verification date.
- DEA notice of intent 2026-20943 (14 Oct 2026, 91 FR 65370) states a temporary order may publish on or after 13 November 2026.
- Mitragynine pseudoindoxyl (MGPI), MGM-15, and MGM-16 have been in Schedule I under a temporary order since 26 August 2026 (separate FR action).
Proposed threshold (HHS recommendation, reflected in 2026-20943 / DOJ)
- Greater than 1 mg/g (solids) or 1 mg/mL (liquids), or
- Mitragynine mass relative to 7-OH and/or MGPI less than 100 (alone or combined).
- Below-threshold products: the notice states neither HHS nor DEA has found them “safe to use.”
Timeline
- 26 Aug 2026 — Temporary order places MGPI, MGM-15, MGM-16 in Schedule I.
- 9 Oct 2026 — DOJ announces updated emergency scheduling actions. justice.gov OPA
- 14 Oct 2026 — NOI 2026-20943 (7-OH & MGPI above threshold); July 2026 7-OH NOI withdrawn. GovInfo PDF
- 14 Oct 2026 — NOI 2026-20942 (MGM-15 / MGM-16). GovInfo PDF
- 21 Oct 2026 — SFDPH health alert: MGM-15 in SF overdose death. SFDPH
- On or after 13 Nov 2026 — Earliest date named in 2026-20943 for publishing the temporary order on 7-OH/MGPI above threshold.
Selected coverage
- Dagens ETC (Sweden), by Carolina Lundin. Published 30 October 2026. Headline: “Bensinmacksheroin driver USA in i ny opioidkris: ‘Kommer att döda’.” Swedish; subscription required. Scan + English translation · etc.se article
Educational material, not legal advice. Re-check the Federal Register before quoting “current law.” Corrections: info@7-oh.help with a primary-source citation.